Preclinical Evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated Macrophages
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical Evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated Macrophages
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 8, Issue 7, Pages 959
Publisher
MDPI AG
Online
2019-07-03
DOI
10.3390/jcm8070959
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Momelotinib sensitizes glioblastoma cells to temozolomide by enhancement of autophagy via JAK2/STAT3 inhibition
- (2019) Tie Liu et al. ONCOLOGY REPORTS
- Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model
- (2019) Benedikt Linder et al. Cancers
- PD-1/PD-L1 immune-checkpoint inhibitors in glioblastoma: A concise review
- (2019) Mario Caccese et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Brain-Cortex Microglia-Derived Exosomes: Nanoparticles for Glioma Therapy
- (2018) Adriana-Natalia Murgoci et al. CHEMPHYSCHEM
- Overexpression of IL-9 induced by STAT3 phosphorylation is mediated by miR-155 and miR-21 in chronic lymphocytic leukemia
- (2018) Na Chen et al. ONCOLOGY REPORTS
- Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation
- (2018) Brian C. Betts et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The critical role that STAT3 plays in glioma-initiating cells: STAT3 addiction in glioma
- (2018) Debolina Ganguly et al. Oncotarget
- Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis
- (2018) John Mascarenhas et al. JAMA Oncology
- Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer
- (2018) Jieru Zhou et al. Cancer Immunology Research
- The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell line
- (2017) Yasuto Akiyama et al. IMMUNOLOGY LETTERS
- MiR-21: A key player in glioblastoma pathogenesis
- (2017) Mohammad Sadegh Masoudi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype
- (2017) Soliman Oushy et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- The JAK2/STAT3 inhibitor pacritinib effectively inhibits patient-derived GBM brain tumor initiating cells in vitro and when used in combination with temozolomide increases survival in an orthotopic xenograft model
- (2017) Katharine Victoria Jensen et al. PLoS One
- STAT3-mediated activation of miR-21 is involved in downregulation of TIMP3 and neovascularization in the ischemic retina
- (2017) Diana R. Gutsaeva et al. Oncotarget
- Inhibition of Farnesyltransferase Potentiates NOTCH-Targeted Therapy against Glioblastoma Stem Cells
- (2017) Yufang Ma et al. Stem Cell Reports
- B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients
- (2016) Y. Yao et al. CLINICAL CANCER RESEARCH
- The role of microglia and macrophages in glioma maintenance and progression
- (2016) Dolores Hambardzumyan et al. NATURE NEUROSCIENCE
- Targeting strategies on miRNA-21 and PDCD4 for glioblastoma
- (2015) Gang Wang et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
- (2015) Wenchao Zhou et al. NATURE CELL BIOLOGY
- Therapeutic targeting of tumor-associated macrophages and microglia in glioblastoma
- (2014) Robert L Bowman et al. Immunotherapy
- Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line
- (2014) TADASHI ASHIZAWA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- miR-146a promotes the initiation and progression of melanoma by activating Notch signaling
- (2014) Matteo Forloni et al. eLife
- Sequence-Dependent Synergistic Inhibition of Human Glioma Cell Lines by Combined Temozolomide and miR-21 Inhibitor Gene Therapy
- (2012) Xiaomin Qian et al. MOLECULAR PHARMACEUTICS
- On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells
- (2012) Owen D. Stechishin et al. NEURO-ONCOLOGY
- Rai is a New Regulator of Neural Progenitor Migration and Glioblastoma Invasion
- (2012) Barbara Ortensi et al. STEM CELLS
- Glioma-astrocyte interaction modifies the astrocyte phenotype in a co-culture experimental model
- (2009) Gagliano ONCOLOGY REPORTS
- Proliferation of Human Glioblastoma Stem Cells Occurs Independently of Exogenous Mitogens
- (2009) John J. P. Kelly et al. STEM CELLS
- Cancer Stem Cells Are Enriched in the Side Population Cells in a Mouse Model of Glioma
- (2008) M. A. Harris et al. CANCER RESEARCH
- PDCD4gene silencing in gliomas is associated with 5′CpG island methylation and unfavourable prognosis
- (2008) Fei Gao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
- (2008) Johan Skog et al. NATURE CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search